Rising Tide Foundation for Clinical Cancer Research (RTFCCR) Clinical Research Grants
Brown University’s RTFCCR Clinical Research Grants fund innovative, patient-focused Phase I–III cancer clinical trials to advance treatment and quality of life.
Funder: Brown University
Due Dates: June 22, 2026 (Letter of Intent) | November 23, 2026 (Letter of Intent, SmartSimple portal closes 23:59 CET)
Funding Amounts: Amount not specified; supports substantial, multi-year Phase I–III interventional cancer clinical trials.
Summary: Supports innovative, patient-centered Phase I–III cancer clinical trials worldwide to advance treatment and quality of life.
Key Information: Only interventional Phase I–III trials; basic research, Phase IV, and observational studies are not eligible.
Description
The program funds innovative, patient-focused interventional clinical trials (Phase I–III) in cancer, aiming to expand treatment options and improve the quality of life for patients globally. Grants are open to academic and not-for-profit institutions, supporting research that advances cancer detection, treatment, or implementation strategies. The program does not support basic research, Phase IV trials, or observational studies, focusing solely on projects that directly test interventions in clinical settings. Patient partner involvement in study protocol design is encouraged, and pre-application grants are available to facilitate patient engagement in the development of proposals.
